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Endocannabinoid (EC) levels are governed by the balance between synthesis, metabolism and trans-membrane transport. It is thus important to understand the factors regulating intracellular and extracellular EC concentrations. We  and we have, therefore, examined the effects of different excitatory stimuli, of  URB597 and , an inhibitor of the major AEA catabolic enzyme {fatty acid amide hydrolase (FAAH)}, MAFP (methoxy fluorophosphonate;) an irreversible inhibitors of fatty acid amide hydrolase FAAH)), FAAH inhibitor and VDM11 {a potent and selective inhibitor of the anandamide membrane transporter (AMT)} on intra- and extracellular ECs in a brain slice preparation.
Mini-prisms (350×350μm) were prepared from the cerebral cortices of male Lister Hooded rats (>250g). Following a 60 min incubation in Krebs Henseleit buffer (KHB, pH 7, 37oC) 50μl aliquots of slices were transferred to 5ml insert vials containing KHB with 1% BSA , final volume 500 μl, and exposed to drugs for 20 min, after which the slices were separated from the medium by rapid filtration under vacuum. Medium and slices were rapidly frozen in liquid nitrogen and stored at -80oC prior to assay. Following organic solvent and solid phase extraction, EC levels were measured by liquid chromatography-tandem mass spectrometry (Richardson et al.,(2007)Anal Biochem reference?. Statistical analysis (Student’s t-test) compared basal levels with those following drug exposure.
Depolarizing levels of KCl (50 mM) stimulated enhanced anandamide (AEA) and oleoylethanolamide (OEA) )synthesislevels  in the tissue by 2.7±0.2 fold (n=4, P =0.001; mean ± s.e.m.) and 2.03 ±0.216 fold (n=3, P=0.0079) respectively whilst no changes were observed for 2-arachidonoyl glycerol (2-AG ) or palmitoyl-ethanolamide (PEA). Stimulation of excitatory amino acid receptors by glutamate (10 mM) enhanced AEA synthesis non-significantly by 1.9±0.6 fold (n=3, P=0.2309) with no effect on other ECs. The cholinergic receptor agonist carbachol (1mM) and the TRPV1 agonist capsaicin (1μM)  slightly increased AEA synthesis by 1.2 fold (n=9, P=0.3), but had no effects on AEA, 2-AG, OEA or PEA. The TRPV1 agonist capsaicin (1μM) had no effect.. Blockade of FAAH by URB597 (1μM) significantly increased anandamide levels in the slices of AEA (3.2±0.3 fold, n=33 P<0.0001), OEA by 2.0±0.2 fold (n=30, P=0.0001) and PEA by 1.5±0.1 fold (n=25, P=0.0227) but had no effect on 2-AG. The increased EC levels due to URB597 were not altered in the presence of the CB1 receptor antagonist (SR141617A, 1μM), ,the TRPV1 antagonist, capsazepine (1μM) or VDM11 (1,5 and 10 μM). 
MAFP(10 µM) significantly increased AEA and OEA levels in tissuesthe slices  by 2.768±0.54 fold (n=6, P=0.0274) and 2.3±0.42 (n=6, P=0.0162) respectively.
 It had no significant effects on increased PEA  or 2-AGlevels not significantly by 1.69±0.23 (n=6, P=0.051), but had no effect on 2-AG.  VDM11 (AMT inhibitor) did not affect EC tissue levels.
Basal EC levels detected in the medium were; AEA (0.5±0.1), 2-AG (2.9±0.8), OEA (39.2±8.31) and PEA (243.1±37.4) pmol/ml. These were enhanced by URB597; AEA by 4.3±0.6 fold (n=5, P=0.0190), OEA 1.9±0.2 fold (n=5, P=0.0087) but PEA 1.3±0.07 fold (n=5, P=0.39) and 2-AG 1.3±0.2 fold (n=5, P=0.4801) non-significantly. The effects of the other drugs on extracellular ECs mirrored tissue changes with the exception that no increased release was observed with K+ (50 mM) or carbachol while VDM11 managed to increased the release of AEA, OEA and PEA non significantly by 1.5 fold non significantly, with no effect on release of 2-AG. but w When combined with URB597 VDM11 increased ptentiated 2-AG release by (4.1 fold) which we previously showed that URB597 was not able to produce this effect when administered alone.
The data presented indicate differential effects of excitatory stimuli on EC levels in brain slices and provide no evidence for tonic regulation of synthesis by CB1 or TRPV1 receptors. The effects of URB597 suggest a high turnover rate of AEA, PEA and OEA in this preparation and that 2-AG is not subject to catabolism by FAAH. The release of ECs from cortical slices appears, in the main, to be passively driven by the trans-membrane concentration gradient. The cortical slice preparation provides, therefore, a suitable in vitro model for the investigation of EC synthesis, metabolism and release in the brain.






